Showing results (631-640 of 764) with videos related to

Sort By:
Pageof 77
BMC Infectious Diseases|November 10, 2020
Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in BaltimoreOluwaseun Falade-Nwulia, Jada Hackman, Shruti H Mehta, et al.
The Lancet. Oncology|February 13, 2010
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 studyDavid Thomas, Robert Henshaw, Keith Skubitz, et al.
Current Biology : CB|November 22, 2022
Efficacy of a novel shark bycatch mitigation device in a tuna longline fisheryPhilip D Doherty, Robert Enever, Lucy C M Omeyer, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|July 26, 2022
Enteropathogenic Escherichia coli (EPEC) expressing a non-functional bundle-forming pili (BFP) also leads to increased growth failure and intestinal inflammation in C57BL/6 miceSolanka Ellen Ledwaba, David Thomas Bolick, Pedro Henrique Quintela Soares de Medeiros, et al.
Pain|May 19, 2015
Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reportingR Andrew Moore, Philip J Wiffen, Christopher Eccleston, et al.
Scandinavian Journal of Work, Environment & Health|June 29, 2006
Brain tumors and occupational exposures in a cohort of female textile workers in Shanghai, ChinaLaura S Gold, Anneclaire J De Roos, Roberta M Ray, et al.
The Oncologist|July 3, 2026
Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 populationNinna Aggerholm-Pedersen, Mette Møller Handrup, Stine Bogestofte Thomassen, et al.
Pain|July 18, 2018
Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacyNanna B Finnerup, Simon Haroutounian, Ralf Baron, et al.
Nature Chemical Biology|June 4, 2013
Identification of small molecules for human hepatocyte expansion and iPS differentiationJing Shan, Robert E Schwartz, Nathan T Ross, et al.
The Medical Journal of Australia|August 24, 2018
Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal-seeking studies of targeted therapies for rare and neglected cancersSubotheni Thavaneswaran, Lucille Sebastian, Mandy Ballinger, et al.
Pageof 77